Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inhibitors of protein geranylgeranylation developed at Baldacci as antitumor agents

July 13, 1999

Indena presents novel paclitaxel derivatives with excellent antitumor activity

July 13, 1999

Structurally novel antitumor and immunosuppressive compounds from Klinge

July 13, 1999

Orphan Medical, Pierre Fabre sign letter of intent to license Busulfex

July 12, 1999

Antitumor and antibacterial compound isolated from cultures of Streptomyces at Kyowa Hakko

July 12, 1999

MetXia-P450 for GDEPT of cancer

July 9, 1999

Gene therapy AD21 evaluated in phase I study in cancer patients

July 9, 1999

Novel FGF discovered at Genentech; antibodies useful for treating, diagnosing tumors

July 9, 1999

NeoPharm announces CRADA with NCI for novel anticancer compound

July 9, 1999

Development candidates selected from series of highly potent ellipticine/olivacine derivatives

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...